Profile data is unavailable for this security.
About the company
IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Company’s film technologies, including VersaFilm, DisinteQ, VetaFilm and transdermal VevaDerm, allows for pharmaceutical products that address unmet medical needs. It provides comprehensive pharmaceuticals services to pharmaceutical partners, including research and development (R&D), analytical method development, clinical monitoring, IP and regulatory services. Its manufacturing facility offers full service by providing lab-scale to pilot- and commercial-scale production. Its product portfolio includes Migraine (Rizatriptan), Erectile Dysfunction (Tadalafil), Schizophrenia (Lozapine), Neurodegenerative, Opioid Dependence (Buprenorphine / Naloxone) and others.
- Revenue in CAD (TTM)1.43m
- Net income in CAD-15.03m
- Incorporated1999
- Employees48.00
- LocationIntelgenx Technologies Corp6420 Abrams StSAINT-LAURENT H4S 1Y2CanadaCAN
- Phone+1 (514) 331-7440
- Fax+1 (514) 331-7440
- Websitehttps://www.intelgenx.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Charlotte's Web Holdings Inc | 79.40m | -41.58m | 34.59m | 164.00 | -- | 0.544 | -- | 0.4357 | -0.271 | -0.271 | 0.5172 | 0.4044 | 0.3668 | 1.07 | 27.08 | 484,130.10 | -19.21 | -25.71 | -22.16 | -29.03 | 55.88 | 48.98 | -52.37 | -63.11 | 2.33 | -- | 0.478 | -- | -14.82 | -1.90 | 59.88 | -- | -7.88 | -- |
| Nurexone Biologic Inc | 0.00 | -5.26m | 34.89m | 8.00 | -- | 6.92 | -- | -- | -0.1123 | -0.1123 | 0.00 | 0.0752 | 0.00 | -- | -- | -- | -124.70 | -213.78 | -146.79 | -596.97 | -- | -- | -- | -- | -- | -- | 0.0066 | -- | -- | -- | 55.45 | -- | -- | -- |
| Briacell Therapeutics Corp | 0.00 | -17.18m | 36.60m | 5.00 | -- | -- | -- | -- | -1.11 | -1.11 | 0.00 | -0.6883 | 0.00 | -- | -- | -- | -54.70 | -59.37 | -60.36 | -63.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 24.35 | -- | -- | -- |
| Medexus Pharmaceuticals Inc | 157.69m | 8.01m | 39.62m | 98.00 | 4.46 | 0.9836 | 2.48 | 0.2513 | 0.363 | 0.363 | 7.25 | 1.65 | 0.7547 | 2.19 | 5.44 | 1,609,050.00 | 3.83 | -6.83 | 8.44 | -9.79 | 52.91 | 53.90 | 5.08 | -11.45 | 0.7013 | 0.9426 | 0.6388 | -- | 40.93 | 69.17 | 142.41 | -- | -8.59 | -- |
| Immunoprecise Antibodies Ltd | 23.68m | -14.26m | 39.79m | 102.00 | -- | 0.7985 | -- | 1.68 | -0.4154 | -0.4154 | 0.6887 | 1.39 | 0.2939 | 5.25 | 6.76 | 170,370.70 | -17.70 | -23.62 | -19.62 | -27.25 | 51.88 | 57.18 | -60.23 | -76.18 | 1.38 | -- | 0.2241 | -- | 6.72 | 30.59 | -58.96 | -- | 34.04 | -- |
| Eastwood Bio-Medical Canada Inc | 736.75k | -531.60k | 41.33m | -- | -- | -- | -- | 56.10 | -0.0077 | -0.0077 | 0.0107 | -0.013 | 1.63 | -- | 38.65 | -- | -117.75 | -52.23 | -- | -140.29 | 60.00 | 52.09 | -72.15 | -52.90 | -- | -227.16 | -- | -- | -33.22 | 3.13 | -264.69 | -- | -- | -- |
| IntelGenx Technologies Corp. | 1.43m | -15.03m | 41.92m | 48.00 | -- | -- | -- | 29.27 | -0.0861 | -0.0861 | 0.0082 | -0.1199 | 0.1245 | 14.36 | 1.74 | -- | -130.62 | -75.15 | -- | -133.79 | -66.03 | -- | -1,049.48 | -819.85 | 0.1153 | -4.88 | 23.66 | -- | 9.37 | -10.65 | 7.14 | -- | -30.32 | -- |
| Microbix Biosystems Inc | 23.84m | 4.06m | 43.81m | 69.00 | 10.83 | 1.58 | 8.02 | 1.84 | 0.0296 | 0.0296 | 0.173 | 0.202 | 0.6703 | 1.67 | 6.33 | -- | 11.42 | -0.9729 | 12.72 | -1.17 | 54.38 | 52.30 | 17.04 | -1.55 | 4.98 | 3.53 | 0.1948 | -- | -13.43 | 5.71 | -102.21 | -- | -3.56 | -- |
| MustGrow Biologics Corp | 4.71m | -665.06k | 48.17m | 0.00 | -- | 10.64 | -- | 10.22 | -0.0134 | -0.0134 | 0.0936 | 0.0912 | 0.7632 | -- | 45.31 | -- | -10.77 | -50.41 | -14.00 | -59.28 | -- | -- | -14.11 | -298.73 | -- | -- | 0.1393 | -- | 72,619.13 | 372.54 | 87.84 | -- | -- | -- |
| Helix Biopharma Corp. | 0.00 | -5.65m | 48.18m | 9.00 | -- | -- | -- | -- | -0.0277 | -0.0277 | 0.00 | -0.0012 | 0.00 | -- | -- | 0.00 | -318.95 | -261.49 | -574.76 | -- | -- | -- | -- | -- | -- | -2,825.00 | -- | -- | -- | -- | 4.16 | -- | -28.36 | -- |
| Auxly Cannabis Group Inc | 102.35m | -60.27m | 50.12m | 369.00 | -- | 0.4809 | -- | 0.4897 | -0.0596 | -0.0596 | 0.1017 | 0.0832 | 0.3454 | 2.26 | 5.92 | 277,374.00 | -20.34 | -21.47 | -30.18 | -24.99 | 7.93 | 5.08 | -58.89 | -124.15 | 0.3836 | -1.40 | 0.4399 | -- | 6.99 | 166.85 | 65.84 | -- | -40.92 | -- |
